Medlab Clinical Future Growth

How is Medlab Clinical forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

Future Growth Score

3/6

Future Growth Score 3/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


-10.1%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

ASX:MDC - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/202513-6N/A-91
6/30/20247-20N/A-192
6/30/20236-16N/A-132
6/30/20222-8-9-9N/A
3/31/20221-9-10-10N/A
12/31/20214-12-11-11N/A
9/30/20214-12-11-11N/A
6/30/20211-10-10-10N/A
3/31/20211-10-9-9N/A
12/31/20201-11-8-8N/A
9/30/20202-12-10-9N/A
6/30/20203-13-11-10N/A
3/31/20204-12-11-11N/A
12/31/20194-12-12-12N/A
9/30/20195-10-11-11N/A
6/30/20195-8-11-10N/A
3/31/20195-7-9-9N/A
12/31/20185-6-7-7N/A
9/30/20184-5-6-6N/A
6/30/20184-5-5-5N/A
3/31/20184-4-5-5N/A
12/31/20175-4-5-5N/A
9/30/20175-4-4-4N/A
6/30/20174-4-4-4N/A
3/31/20174-4-4-4N/A
12/31/20164-4-4-4N/A
9/30/20163-4-4-4N/A
6/30/20163-3-4-4N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: MDC is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: MDC is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: MDC is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: MDC's revenue (49.5% per year) is forecast to grow faster than the Australian market (3.6% per year).

High Growth Revenue: MDC's revenue (49.5% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: MDC's Return on Equity is forecast to be high in 3 years time (29.6%)


Discover growth companies